Cotización Pharmagen (CE) - PHRX

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Último Precio

0.000001

Postura de Compra

0.00

Postura de Venta

0.00

Volume Operado de la Acción

0.00 Rango del Día 0.00

0.000001 Rango de 52 semanas 0.0001

Precio Anterior

0.000001

Precio de Apertura

Hora

Última hora de negociación

Volumen promedio (3 m)

11,179

Volumen financiero

Precio Promedio Ponderado

Pharmagen Appoints Industry Veteran Russell Skibsted as Chief Financial Officer ("CFO ")

Pharmagen Appoints Industry Veteran Russell Skibsted as Chief Financial Officer ("CFO ") PR Newswire SILVER SPRING, Md., June 11, 2014 SILVER SPRING, Md., June 11, 2014 /PRNewswire/...

Pharmagen Appoints Additional Members to its Board of Directors

Pharmagen Appoints Additional Members to its Board of Directors PR Newswire SILVER SPRING, Md., May 29, 2014 SILVER SPRING, Md., May 29, 2014 /PRNewswire/ -- Pharmagen, Inc. (OTCPink: PHRX) (the...

Pharmagen Recruits Frederick W. Mundt as Senior Vice President of Sales

Pharmagen Recruits Frederick W. Mundt as Senior Vice President of Sales PR Newswire SILVER SPRING, Md., May 6, 2014 SILVER SPRING, Md., May 6, 2014 /PRNewswire/ -- Pharmagen, Inc. (OTCPINK: PHRX...

Boyd Relac joins the Pharmagen Executive Team as Chief Operating Officer ("COO")

Boyd Relac joins the Pharmagen Executive Team as Chief Operating Officer ("COO") PR Newswire SILVER SPRING, Md., April 29, 2014 SILVER SPRING, Md., April 29, 2014 /PRNewswire/...

Pharmagen Completes Bridge Financing to Support Consolidation and Capital Restructure Plan

Pharmagen Completes Bridge Financing to Support Consolidation and Capital Restructure Plan PR Newswire SILVER SPRING, Md., April 22, 2014 SILVER SPRING, Md., April 22, 2014 /PRNewswire/...

Pharmagen Partners with Bagel Boy Equity Group II, LLC and prepares to Launch its Industry Consolidation Strategy

Pharmagen Partners with Bagel Boy Equity Group II, LLC and prepares to Launch its Industry Consolidation Strategy PR Newswire SILVER SPRING, Md., Dec. 17, 2013 SILVER SPRING, Md., Dec. 17, 2013...

Pharmagen Announces Third Quarter 2013 Results

Pharmagen Announces Third Quarter 2013 Results PR Newswire SILVER SPRING, Md., Nov. 14, 2013 SILVER SPRING, Md., Nov. 14, 2013 /PRNewswire/ -- Pharmagen, Inc. (OTCQB: PHRX) (the "Company" or...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0	0	0	0	0	CS
4	0	0	1.0E-6	0.0001	1.0E-6	7442	1.0E-6	CS
12	0	0	1.0E-6	0.0001	1.0E-6	11179	1.0E-6	CS
26	0	0	1.0E-6	0.0001	1.0E-6	8719	1.0E-6	CS
52	0	0	1.0E-6	0.0001	1.0E-6	8407	1.0E-6	CS
156	0	0	1.0E-6	0.0003	1.0E-6	12661	4.03E-5	CS
260	-0.000699	-99.8571428571	0.0007	0.0039	1.0E-6	212478	0.0006274	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
NEPTFNeptune Wellness Solutions Inc (CE)	US$ 0.0238 (2,379,900.00%)	13.46k
CNVIFConavi Medical Corporation (PK)	US$ 0.58 (82,757.14%)	2.25k
FUNFFFansUnite Entertainment Inc (CE)	US$ 0.00055 (54,900.00%)	342.7k
RQHTFReliq Health Technologies Inc (CE)	US$ 0.0003 (29,900.00%)	219.11k
ELOXEloxx Pharmaceuticals Inc (CE)	US$ 0.0001 (9,900.00%)	1.53k
FDVXFFenixOro Gold Corporation (CE)	US$ 0.000001 (-100.00%)	10k
TMPOQTempo Automation Holdings Inc (CE)	US$ 0.000001 (-99.98%)	200
HLLPFHello Pal International Inc (CE)	US$ 0.000001 (-99.90%)	6k
MOTSMotus GI Holdings Inc (CE)	US$ 0.000001 (-99.88%)	649
BTAEFBeta Energy Corporation (CE)	US$ 0.000001 (-99.67%)	655
RSHNRushNet Inc (PK)	US$ 0.00015 (-25.00%)	502.31M
EARIEntertainment Arts Research Inc (PK)	US$ 0.0001 (0.00%)	428.38M
ASTAAstra Veda Corporation (PK)	US$ 0.0002 (-33.33%)	364.38M
RDARRaadr Inc (PK)	US$ 0.0009 (50.00%)	276.07M
CGACCode Green Apparel Corp (PK)	US$ 0.00065 (44.44%)	225.16M

Tendencias Ahora

Listas Principales

Datos

Noticias

Herramientas

Mercados

Descubrir

Hot Features

Follow Feed

Flujo de Opciones

Monitor

Pharmagen Inc (CE) (PHRX) Cotización

Pharmagen Inc (CE) (PHRX)

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

PHRX Últimas noticias

Pharmagen Appoints Industry Veteran Russell Skibsted as Chief Financial Officer ("CFO ")

Pharmagen Appoints Additional Members to its Board of Directors

Pharmagen Recruits Frederick W. Mundt as Senior Vice President of Sales

Boyd Relac joins the Pharmagen Executive Team as Chief Operating Officer ("COO")

Pharmagen Completes Bridge Financing to Support Consolidation and Capital Restructure Plan

Pharmagen Partners with Bagel Boy Equity Group II, LLC and prepares to Launch its Industry Consolidation Strategy

Pharmagen Announces Third Quarter 2013 Results

Movimientos

PHRX Discussion

Su Consulta Reciente

Empresa

Negocios

Popular

Obtener la aplicación